Literature DB >> 25750085

Global and regional brain glucose metabolism decline after systemic chemotherapy.

Saeid Gholami1, Eivind Antonsen Segtnan, Abass Alavi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25750085     DOI： 10.1007/s00259-015-3023-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

Review 1.  Integrating imaging findings in evaluating the post-chemotherapy brain.

Authors:  K L Pomykala; M B de Ruiter; S Deprez; B C McDonald; D H S Silverman
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

2.  Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease.

Authors:  Erik S Musiek; Babak Saboury; Shipra Mishra; Yufen Chen; Janet S Reddin; Andrew B Newberg; Jayaram K Udupa; John A Detre; Frank Hofheinz; Drew Torigian; Abass Alavi
Journal:  Hell J Nucl Med       Date:  2012-10-25       Impact factor: 1.102

3.  Adverse functional effects of chemotherapy on whole-brain metabolism: a PET/CT quantitative analysis of FDG metabolic pattern of the "chemo-brain".

Authors:  Jordan Sorokin; Babak Saboury; JinHyung Albert Ahn; Mateen Moghbel; Sandip Basu; Abass Alavi
Journal:  Clin Nucl Med       Date:  2014-01       Impact factor: 7.794

Review 4.  Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target.

Authors:  J S Wefel; A E Kayl; C A Meyers
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

5.  Systemic chemotherapy decreases brain glucose metabolism.

Authors:  Laura L Horky; Victor H Gerbaudo; Alexander Zaitsev; Wen Plesniak; Jon Hainer; Usha Govindarajulu; Ron Kikinis; Jörg Dietrich
Journal:  Ann Clin Transl Neurol       Date:  2014-10-01       Impact factor: 4.511
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.